U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07551336) titled 'Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma' ... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07551323) titled 'Comparison of the Effectiveness of Myofascial Release Technique and Pilates Exercises in C... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07551258) titled 'Innate Immune Immunoparalysis and Ventilator-Associated Pneumonia in Critically Ill Elderl... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549243) titled 'Transcutaneous Auricular Vagus Nerve Stimulation for Preventing Acute Kidney Injury in Pat... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549802) titled 'The Effect of Inspiratory Muscle Warm-up' on April 10. Brief Summary: The purpose of this... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550179) titled 'Labial White Spot Lesions And Proximal Caries Development In Orthodontic Patients Using Cl... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550777) titled 'Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal Bevacizumab... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549594) titled 'Prophylaxis of Recurrent Erysipelas in Lower Limbs: compreSsion thErapy vs aNTibiotics and... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550920) titled 'Relatrilfa-α Plus Single-Agent Chemotherapy as Neoadjuvant Therapy for Resectable Sta... Read More
U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550673) titled 'Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Coliti... Read More